News
16h
Zacks.com on MSNLyra Stock Soars 356% in a Week on Strong Rhinosinusitis Study SuccessLYRA skyrockets 356% after its lead nasal implant, LYR-210, meets key goals in a pivotal phase III chronic rhinosinusitis study.
The transaction is subject to customary regulatory approvals and is expected to close in the third quarter of 2025, a joint ...
21h
Zacks Investment Research on MSNArista Stock Surges 12.5% in 3 Months: Worth a Solid Buy?Riding on a software-driven, data-centric approach that helps customers build their cloud architecture, Arista Networks, Inc.
SaaS provider integrates audience insights and data activation capabilities into its digital experience platform five months ...
EngageLab Contract Value: 63 million RMB newly signed in Q1 2025, bringing the total cumulative contract value to over 110 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results